Tauropace reduces infections in patients with heart failure and reduced ejection fraction after cardiac electronic implantable device implantation.
30 March 2025 (08:00 - 15:30)
Organised by: 

About the speaker

Istituto Cardiocentro Ticino, Lugan (Switzerland)
6 More presentations in this session

Mrs M. Upchurch (Minneapolis, US)

Assistant Professor G. Leventopoulos (Patras, GR)
Access the full session
The Event
EHRA 2025
30 March - 1 April 2025
You may be interested in
Congress Session



